This inventor holds 1 USPTO granted patent. Top assignee: Cancer Research Technology Limited. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: John Thomas Gallagher: Innovator in Saccharide Analysis
Introduction
John Thomas Gallagher is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of saccharide analysis, particularly through his innovative methods for analyzing and sequencing saccharide materials. His work has implications in various scientific and medical fields, especially in understanding complex carbohydrates.
Latest Patents
Gallagher holds a patent for a method titled "Sequence analysis of saccharide material." This patent describes a technique for analyzing and sequencing saccharide chains by employing a controlled partial depolymerization process. The method involves labeling or tagging the reducing ends of saccharide chains and using specific reagents to cleave internal glycosidic linkages. This results in a mixed set of saccharide chain fragments, which are then analyzed to deduce the monosaccharide sequence in the original saccharide material.
Career Highlights
John Thomas Gallagher is associated with Cancer Research Technology Limited, where he applies his expertise in saccharide analysis. His work is crucial in advancing research related to cancer and other diseases, where understanding carbohydrate structures can lead to better diagnostic and therapeutic strategies.
Collaborations
Gallagher has collaborated with notable colleagues, including Jeremy Ewan Turnbull and John Joseph Hopwood. These collaborations have likely enriched his research and contributed to the development of innovative solutions in the field of saccharide analysis.
Conclusion
John Thomas Gallagher's contributions to the analysis of saccharide materials highlight his role as an important inventor in the scientific community. His patented methods pave the way for advancements in research and applications in health and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile